Genetron is a Beijing-based firm that employs gene detection to support cancer treatment. The company announced a new funding round totaling over 500 million yuan (about $71 million). The announcement named Vivo Capital among the investors and referenced other participating backers. The report was brief and focused on the size of the raise rather than operational details. No financing terms, use of proceeds, or additional investor identities were disclosed in the announcement.

Total raised

$71M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2019